Synthesis of Tn, sialyl Tn and HIV-1-derived peptide antigen conjugates having a lipid a analog as an immunoadjuvant for synthetic vaccines

Chemical and Pharmaceutical Bulletin

Volumn 46, Issue 11, 1998, Pages 1676-1682

  Miyajima, Keisuke ^a   Nekado, Takahiro ^a   Ikeda, Kiyoshi ^a   Achiwa, Kazuo ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

HIV 1 derived peptide; Lipid A analog; Mitogenic activity; Sialyl Tn; Synthetic vaccine; Tn

Indexed keywords

GLUCOSAMINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT; LIPID A; VACCINE; VIRUS ANTIGEN;

ARTICLE; DRUG CONJUGATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; MITOGENESIS;

EID: 0031761539     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.46.1676     Document Type: Article

References (22)

1. a) Galanos C., Lüderitz O., Rietschel E. T., Westphal O., Int. Rev. Biochem., 14, 239-335 (1977);
2. b) Lüderitz O., Galanos C., Lehmann V., Mayer H., Rietschel E. T., Weckesser J., Naturwissenschaften, 65, 578-585 (1978).
3. Ikeda K., Miyajima K., Achiwa K., Chem. Pharm. Bull., 44, 1958-1961 (1996), and references cited therein.
4. a) Miyajima K., Ikeda K., Achiwa K., Chem. Pharm. Bull., 44, 2268-2273 (1996);
5. b) Miyajima K., Achiwa K., ibid., 45, 312-320 (1997);
6. c) Miyajima K., Gomi N., Ikeda K., Achiwa K., ibid., 45, 1089-1093 (1997).
7. Miyajima K., Nekado T., Ikeda K., Achiwa K., Chem. Pharm. Bull., 45, 1544-1546 (1997).
8. a) Maruyama Y., Kurimura M., Achiwa K., Chem. Pharm. Bull., 42, 1709-1711 (1994);
9. b) Toyokuni T., Singhal A. K., Chem. Soc. Rev., 231-242 (1995);
10. c) Déprez B., Gras-Masse H., Martinon F., Gomard E., Lévy J.-P., Tartar A., J. Med. Chem., 38, 459-465 (1995).
11. Takeshita T., Takahashi H., Kozlowski S., Ahlers J. D., Pendleton C. D., Moore R. L., Nakagawa Y., Yokomuro K., Fox B. S., Margulies D. H., Berzofsky J. A., J. Immunol., 154, 1973-1986 (1995).
12. a) Itzkowitz S. H., Yuan M., Montgomery C. K., Kjeldsen T., Takahashi H. K., Bigbee W. L., Kim V. S., Cancer Res., 49, 197-204 (1989);
13. b) Hakomori S.-I., Adv. Cancer Res., 52, 257-331 (1889).
14. Hansen J.-E. S., Clause H., Hu S. L., Nielsen J. O., Olofsson S., Arch. Virol., 126, 11-20 (1992).
15. a) Iijima H., Ogawa T., Carbohydr. Res., 172, 183-193 (1988);
16. b) Nakahara Y., Iijima H., Shibayama S., Ogawa T., Carbohydr. Res., 216, 211-225 (1991);
17. c) Kunz H., Liebe B., Tetrahedron Lett., 35, 8777-8778 (1994);
18. d) Elofsson M., Salvador L. A., Kihlberg J., Tetrahedron, 53, 369-390 (1997).
19. Lemieux R. U., Ratcliffe R. M., Can. J. Chem., 57, 1244-1251 (1979).
20. Nagao Y., Nekado T., Ikeda K., Achiwa K., Chem. Pharm. Bull., 43, 1536-1542 (1995).
21. Van Der Vleugel D. J. M., Wassenburg F. R., Zwikker J. W., Vliegenthart J. F. G., Carbohydr. Res., 104, 221-233 (1982).
22. Shimizu T., Akiyama S., Masuzawa T., Yanagihara Y., Nakamoto S., Achiwa K., Infect Immun., 55, 2287-2289 (1987).